Brief: Medmen Reports Q2 Loss Per Share From Continuing Operations Of $0.09
Feb 26 (Reuters) - Medmen Enterprises Inc MMEN.CD :
* MEDMEN REPORTS SECOND QUARTER FISCAL 2020 FINANCIAL
RESULTS –
DESIGNATED NEWS RELEASE
* Q2 REVENUE $44.1 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$50.2
MILLION
* ANNOUNCES SALE OF NON-CORE ILLINOIS CULTIVATION LICENSE
FOR
TOTAL GROSS PROCEEDS OF $17 MILLION
* QTRLY LOSS PER SHARE FROM CONTINUING OPERATIONS $0.09
Source text for Eikon: ID:nBw9qT3D5a
Further company coverage: MMEN.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medmen Enterprises
See all newsBrief: MedMen Announces Entering Bankruptcy Proceedings And Resignation Of CFO And Directors
Brief: MedMen Exits Arizona Market, Completing Sale Of Local Operations To Mint Cannabis
Brief: Medmen Enters Into Definitive Agreements To Exit Arizona And Nevada Per Announced Strategic Review, Selling Non-Core Assets To Mint Cannabis
Brief: Medmen Announces Ellen Deutsch As CEO And Amit Pandey As CFO
Brief: Medmen Continues Restructuring Efforts, Highlights Results To-Date